CFN Media Interviews ChineseInvestors.com CEO Warren Wang
Ryan Allway
June 29th, 2017
News, Top News
ChineseInvestors.com Inc. (OTCQB: CIIX), a provider of real-time market analysis for U.S.-based Chinese investors, recently announced its entry into the cannabis industry with the development CBD Biotechnology Inc. in British Columbia, Canada.
CFN Media sat down with CEO Warren Wang to discuss these recent developments and what it means for the future of the company.
Your company, ChineseInvestors.com, has a long history of building and communicating with a large audience of Chinese-speaking investors. Now you are leveraging that audience as your company enters the cannabis market. Why make this move now, and how do you see the two sides of the business supporting and working with each other?
No Chinese publicly traded company has entered the CBD business, so we are the first, which gives us an advantage. In addition, we are not new to the marijuana industry. We have a few years of experience already, having made an investment in Medicine Man Technologies, Inc. (MDCL).
As a result, we feel very well positioned to enter a market that has been estimated by an independent third-party to reach 20 billion in sales by 2020. Although CBD for consumption is not legal in China now, we believe CBD can be as large as the coffee industry once it is legalized. China has 1.4 billion people, so if in the future the Chinese people spend just $1 on CBD, that is double the size of the entire CBD industry now. On the day when that opportunity arrives, we will be there and we will be ready.
You recently incorporated a subsidiary, CBD Biotechnology Inc., in British Columbia, Canada. What is the goal of this new venture? What developments can our audience look for in the near future?
It’s very exciting to be in Canada, because it’s the first G7 country to completely legalize marijuana. Toronto is now the capital city of the marijuana industry. For our business, Canada represents a huge market, as there are nearly 1 million Chinese-Canadian people. We intend to serve these people.
On the Chinese front, you recently launched ChineseHempOil.com. You are also building a retail store in San Gabriel California, offering hemp-based products and geared toward Chinese-speaking residents. What can you tell us about these potential revenue streams and how they fit into your overall business plan?
Our revenue estimate is $700,000 in our 2017 accounting year and 16 million by 2020. We have faced some headwinds with our retail store, owing to difficulties with a conservative landlord. But such headwinds are to be expected in this industry, and we have responded by turning the store into an educational center and showroom.
So we are building awareness and laying the foundation for positive word-of-mouth at the store, while using this high-touch opportunity to direct consumers to buy from us online at ChineseHempOil.com. On the retail front, we are looking forward to launching our CBD-infused cosmetics line in the China market later this year. CBD is approved for use in cosmetics in China and we feel the potential in the marketplace is huge.
You recently announced a partnership with Launch Haus to help you get some of these initiatives off the ground, including the development of your direct-to-consumer e-commerce, and network marketing divisions. Can you talk a little bit about what drew you to Launch Haus, and how the various sales channels will work together to expand your sales?
We were attracted to Launch Haus’s experience and track record and we’re confident that our entry into network marketing will be quite successful. We’ve already received feedback that our product lends itself well to direct selling, so we’re moving quickly on this front. We’re excited at the sales potential that comes from harnessing a growing and enthusiastic network. One of the benefits for us of working with a team of personal sellers is that they educate consumers, which we feel contributes to the word-of-mouth effect.
Please give us some background on your executive team and key hires as your company takes off in a new direction.
We’ve brought on Julie Uhler as Chief Operating Officer for the company. Julie is a successful businesswoman with a strong background in both accounting and marketing. An expert negotiator, she has many years of experience starting and running her own companies, both in China and the U.S. We’re delighted to have Julie in charge of our product line-up and providing leadership in daily operations.
We’ve also added Kate Popejoy as Chief Customer Officer. Kate is an American who has lived in China, speaks Mandarin, and has abundant experience in sales and business. She will be making sure our sales experience goes above and beyond customers’ expectations so we can build our reputation as the go-to brand for Chinese-speakers interested in the benefits of CBD.
What is your vision for the future of ChineseInvestors.com?
My personal vision is that ChineseHempOil.com spins off from ChineseInvestors.com to become a separate company. While there are synergies between the two companies, I think each company has such strong potential I’d like to see them become independent entities so that they can really stretch out their wings and grow. This is my opinion and my dream at this point. It is not the opinion of the board, nor should it be construed as a forward-looking statement.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Pivot Pharmaceuticals Inc. is an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals.
Valens GroWorks is a multi-licensed, vertically integrated provider of Canadian cannabis products with two wholly-owned subsidiaries located in Kelowna, BC.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
